Your browser is no longer supported. Please, upgrade your browser.
Settings
CORT Corcept Therapeutics Incorporated daily Stock Chart
CORT [NASD]
Corcept Therapeutics Incorporated
Index- P/E17.46 EPS (ttm)0.87 Insider Own3.10% Shs Outstand114.58M Perf Week-0.92%
Market Cap1.68B Forward P/E21.48 EPS next Y0.71 Insider Trans-1.85% Shs Float103.16M Perf Month16.73%
Income106.00M PEG- EPS next Q0.23 Inst Own78.10% Short Float21.24% Perf Quarter19.97%
Sales334.90M P/S5.03 EPS this Y29.10% Inst Trans-0.72% Short Ratio19.38 Perf Half Y15.57%
Book/sh3.57 P/B4.24 EPS next Y-23.20% ROA27.30% Target Price15.50 Perf Year51.40%
Cash/sh2.76 P/C5.48 EPS next 5Y- ROE30.00% 52W Range9.55 - 17.48 Perf YTD25.12%
Dividend- P/FCF11.62 EPS past 5Y34.90% ROI24.00% 52W High-13.39% Beta1.10
Dividend %- Quick Ratio10.00 Sales past 5Y63.10% Gross Margin98.20% 52W Low58.53% ATR0.74
Employees206 Current Ratio10.10 Sales Q/Q43.80% Oper. Margin38.90% RSI (14)64.19 Volatility6.30% 5.23%
OptionableYes Debt/Eq0.00 EPS Q/Q66.80% Profit Margin31.60% Rel Volume0.95 Prev Close15.24
ShortableYes LT Debt/Eq0.00 EarningsMay 04 AMC Payout0.00% Avg Volume1.13M Price15.14
Recom2.30 SMA207.81% SMA5019.24% SMA20015.07% Volume1,079,038 Change-0.66%
Sep-24-19Initiated Jefferies Buy $20
Sep-06-19Initiated H.C. Wainwright Buy $18
Feb-04-19Downgrade B. Riley FBR Buy → Neutral $22 → $12
Aug-10-18Reiterated Stifel Hold $20 → $11
May-31-18Downgrade Stifel Buy → Hold $20
Mar-09-18Initiated B. Riley FBR, Inc. Buy $30
Aug-31-17Initiated Stifel Buy $20
Feb-02-17Initiated Ladenburg Thalmann Buy $14
Apr-21-15Initiated FBR Capital Outperform $12
Jan-13-14Downgrade Stifel Buy → Hold
Aug-09-13Downgrade Ladenburg Thalmann Buy → Neutral $3.30
Aug-09-13Downgrade Janney Buy → Neutral
Feb-21-12Reiterated JMP Securities Mkt Outperform $9 → $11
Jan-06-10Upgrade Ladenburg Thalmann Neutral → Buy $4
Jul-17-08Initiated Rodman & Renshaw Mkt Outperform $8
Jun-21-07Upgrade Punk, Ziegel & Co Mkt Perform → Accumulate
May-18-20 06:23AM  Should You Worry About Corcept Therapeutics Incorporated's (NASDAQ:CORT) CEO Pay? Simply Wall St.
May-17-20 09:06PM  Edited Transcript of CORT earnings conference call or presentation 4-May-20 9:00pm GMT Thomson Reuters StreetEvents
May-14-20 04:05PM  Corcept Therapeutics to Present Data at the American Society of Clinical Oncology Annual Meeting GlobeNewswire
May-13-20 01:16PM  6 Stocks John Hussman Continues to Buy GuruFocus.com
May-12-20 07:45AM  Should You Climb on Board the Corcept Therapeutics Train? Motley Fool
May-10-20 10:46PM  Were Hedge Funds Right About Corcept Therapeutics Incorporated (CORT)? Insider Monkey
May-06-20 06:27PM  Corcept Therapeutics Shows Rising Price Performance With Jump To 85 RS Rating Investor's Business Daily
May-05-20 02:50PM  Corcept (CORT) Q1 Earnings Top Estimates, Revenues Rise Y/Y Zacks
08:31AM  New Strong Buy Stocks for May 5th Zacks
08:00AM  These 3 Biotech Stocks Are Outperforming Their Peers Here's Why Investor's Business Daily
01:02AM  Corcept Therapeutics Incorporated (CORT) Q1 2020 Earnings Call Transcript Motley Fool
May-04-20 07:05PM  Corcept Therapeutics (CORT) Tops Q1 Earnings and Revenue Estimates Zacks
04:05PM  Corcept Therapeutics Announces First Quarter 2020 Financial Results And Provides Corporate Update GlobeNewswire
Apr-27-20 04:05PM  Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
12:00PM  Are You Looking for a Top Momentum Pick? Why Corcept Therapeutics (CORT) is a Great Choice Zacks
Apr-22-20 06:43AM  Should You Be Adding Corcept Therapeutics (NASDAQ:CORT) To Your Watchlist Today? Simply Wall St.
Apr-13-20 08:31AM  Corcept Therapeutics' Shares March Higher, Can It Continue? Zacks
Apr-02-20 09:51AM  Why You Shouldn't Bet Against Corcept Therapeutics (CORT) Stock Zacks
Apr-01-20 08:30AM  CORCEPT THERAPEUTICS PUBLISHES ABSTRACT IN THE JOURNAL OF THE ENDOCRINE SOCIETY GlobeNewswire
Mar-26-20 12:06PM  Update: Corcept Therapeutics (NASDAQ:CORT) Stock Gained 88% In The Last Five Years Simply Wall St. +6.59%
Mar-21-20 11:30AM  Corcept (CORT) Down 24.9% Since Last Earnings Report: Can It Rebound? Zacks
Mar-12-20 08:30AM  Corcept Therapeutics Appoints Gregg Alton to Board of Directors GlobeNewswire
Feb-25-20 06:22AM  An Intrinsic Calculation For Corcept Therapeutics Incorporated (NASDAQ:CORT) Suggests It's 25% Undervalued Simply Wall St.
Feb-24-20 12:41PM  Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Corcept Therapeutics Incorporated (CORT) Business Wire
Feb-21-20 02:25PM  Corcept (CORT) Q4 Earnings In-Line with Estimates, Up Y/Y Zacks
Feb-20-20 06:15PM  Corcept Therapeutics (CORT) Meets Q4 Earnings Estimates Zacks
04:05PM  Corcept Therapeutics Announces Fourth Quarter And Full-Year 2019 Audited Financial Results And Provides Corporate Update GlobeNewswire
Feb-19-20 12:10PM  Why Corcept (CORT) Could Beat Earnings Estimates Again Zacks
Feb-18-20 11:04AM  What's in Store for Corcept (CORT) This Earnings Season? Zacks
Feb-17-20 12:30PM  Corcept Therapeutics (CORT) to Report Q4 Results: What Awaits? Zacks
Feb-13-20 04:05PM  Corcept Therapeutics to Announce Audited Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Jan-30-20 04:06PM  Corcept Therapeutics Announces Fourth Quarter and Full-Year 2019 Preliminary Selected Financial Results; Provides 2020 Revenue Guidance GlobeNewswire
06:45AM  How Corcept Therapeutics Incorporated (NASDAQ:CORT) Can Impact Your Portfolio Volatility Simply Wall St.
Jan-09-20 08:40AM  Tyme Initiates Dosing in Pivotal Pancreatic Cancer Study Zacks
Jan-08-20 10:18AM  Tyme Out-Licenses Cancer Candidate to Eagle Pharma, Stock Up Zacks
Jan-07-20 10:21AM  Soleno (SLNO) Ends Enrollment in Prader-Willi Syndrome Study Zacks
09:51AM  Intrexon's Blood Cancer Drug Gets Orphan Drug Status From FDA Zacks
09:17AM  Catalyst Gives Preliminary Firdapse Estimates & Other Updates Zacks
07:54AM  New Strong Buy Stocks for January 7th Zacks
Dec-31-19 07:49AM  Read This Before Selling Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Simply Wall St.
Dec-26-19 07:25PM  Shareholder Alert: Robbins LLP Announces Another Complaint Filed Against Corcept Therapeutics Incorporated (CORT) Business Wire
Dec-10-19 10:46AM  Hedge Funds Are Buying Corcept Therapeutics Incorporated (CORT) Insider Monkey
Dec-07-19 11:31AM  Why Is Corcept (CORT) Down 8.9% Since Last Earnings Report? Zacks
Dec-04-19 07:43AM  Why Corcept Therapeutics Incorporated's (NASDAQ:CORT) High P/E Ratio Isn't Necessarily A Bad Thing Simply Wall St.
Nov-20-19 12:55PM  Edited Transcript of CORT earnings conference call or presentation 7-Nov-19 10:00pm GMT Thomson Reuters StreetEvents -22.08%
Nov-19-19 08:51AM  Can The Uptrend Continue for Corcept Therapeutics? Zacks
Nov-14-19 08:52AM  Options Traders Expect Huge Moves in Corcept (CORT) Stock Zacks
Nov-08-19 10:31AM  Corcept (CORT) Earnings Beat in Q3, Korlym Boosts Sales Zacks
Nov-07-19 07:35PM  Corcept Therapeutics (CORT) Surpasses Q3 Earnings and Revenue Estimates Zacks
04:05PM  Corcept Therapeutics Announces Third quarter 2019  Financial Results and provides corporate update GlobeNewswire
Nov-04-19 06:51AM  Is Corcept Therapeutics Incorporated (NASDAQ:CORT) A High Quality Stock To Own? Simply Wall St.
Oct-31-19 04:05PM  Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
10:33AM  Analysts Estimate Corcept Therapeutics (CORT) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-27-19 02:04PM  Did Hedge Funds Drop The Ball On Corcept Therapeutics Incorporated (CORT) ? Insider Monkey
Oct-14-19 10:10AM  Why Corcept (CORT) is Poised to Beat Earnings Estimates Again Zacks
Oct-09-19 06:11AM  The Corcept Therapeutics (NASDAQ:CORT) Share Price Has Soared 368%, Delighting Many Shareholders Simply Wall St.
Oct-02-19 06:20PM  Shareholder Alert: Robbins Arroyo Announces Another Complaint Filed Against Corcept Therapeutics Incorporated (CORT) Business Wire
Sep-18-19 08:30AM  Corcept Therapeutics Appoints Kimberly Park to Board of Directors GlobeNewswire
Sep-16-19 10:43AM  Corcept Therapeutics Incorporated (NASDAQ:CORT): A Fundamentally Attractive Investment Simply Wall St.
Sep-13-19 01:54PM  5 Health Care Stocks Gurus Are Buying GuruFocus.com
Aug-31-19 09:31AM  Corcept (CORT) Up 15.1% Since Last Earnings Report: Can It Continue? Zacks
Aug-29-19 06:57PM  Edited Transcript of CORT earnings conference call or presentation 1-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-28-19 04:05PM  Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushings Syndrome GlobeNewswire
Aug-27-19 01:05PM  Is Corcept Therapeutics Incorporated's (NASDAQ:CORT) CEO Overpaid Relative To Its Peers? Simply Wall St.
Aug-05-19 09:18AM  Corcept's (CORT) Earnings & Revenues Miss Estimates in Q2 Zacks
Aug-03-19 12:18AM  Corcept Therapeutics Incorporated (CORT) Q2 Earnings Call Transcript Motley Fool
Aug-01-19 07:05PM  Corcept Therapeutics (CORT) Q2 Earnings Beat Estimates Zacks
04:05PM  Corcept Therapeutics Announces Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
08:00AM  Does Corcept Therapeutics Incorporated (NASDAQ:CORT) Have A High Beta? Simply Wall St.
Jul-25-19 04:05PM  Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Jul-09-19 10:03AM  Can We See Significant Insider Ownership On The Corcept Therapeutics Incorporated (NASDAQ:CORT) Share Register? Simply Wall St.
Jun-19-19 12:41PM  Corcept Therapeutics Incorporated (NASDAQ:CORT): Poised For Long Term Success? Simply Wall St.
Jun-08-19 09:30AM  Corcept (CORT) Down 11.3% Since Last Earnings Report: Can It Rebound? Zacks
Jun-01-19 11:37AM  The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace Benzinga
May-30-19 01:21PM  Is Corcept Therapeutics Incorporated's (NASDAQ:CORT) P/E Ratio Really That Good? Simply Wall St.
May-28-19 08:05AM  Corcept Therapeutics to Present Data from Phase 1/2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Solid Tumors at the American Society of Clinical Oncology Annual Meeting GlobeNewswire
May-20-19 07:30AM  Lawsuit for Investors in shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) announced by Shareholders Foundation ACCESSWIRE
May-19-19 10:12PM  Edited Transcript of CORT earnings conference call or presentation 9-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-16-19 10:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Corcept, Mobile TeleSystems, Healthcare Services, and American Renal and Encourages Investors to Contact the Firm GlobeNewswire
May-13-19 03:00PM  CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action GlobeNewswire
10:43AM  DEADLINE MONDAY REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
09:51AM  CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action ACCESSWIRE
09:30AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, HCSG, BA and NOK GlobeNewswire
09:21AM  DEADLINE TODAY: Rosen Law Firm Reminds Corcept Therapeutics Incorporated Investors of Important May 13th Deadline in Securities Class Action Lawsuit - CORT GlobeNewswire
May-12-19 10:20AM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In NIO, CORT, HCSG or FCHS To Contact The Firm GlobeNewswire
May-10-19 05:30PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, FSNN and BSX ACCESSWIRE -5.08%
03:50PM  3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:25PM  CLASS ACTION UPDATE for CORT, FSNN and MWA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:00PM  DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
11:56AM  Corcept Therapeutics Incorporated (CORT) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 07:25PM  Corcept Therapeutics (CORT) Q1 Earnings Top Estimates Zacks
06:23PM  Corcept: 1Q Earnings Snapshot Associated Press
05:30PM  CLASS ACTION UPDATE for CORT, NIO and BSX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
05:21PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corcept Therapeutics Incorporated GlobeNewswire
04:05PM  Corcept Therapeutics Announces First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
03:45PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To Contact The Firm ACCESSWIRE
03:29PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT GlobeNewswire
02:10PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, FSNN and APYX ACCESSWIRE
12:10PM  4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
09:44AM  CLASS ACTION UPDATE for CORT, NIO, MBT and NOK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant that is in Phase III clinical trial to treat patients with Cushing's syndrome; and Abraxane in combination with relacorilant, which is in Phase II clinical trial to treat patients with serous ovarian tumors, as well as in Phase I/II clinical trial for the treatment of solid tumors. The company is also developing selective cortisol modulator combined with Xtandi that is in open label dose finding trial to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator that is in Phase II for the treatment of antipsychotic-induced weight gain; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAKER G LEONARD JRDirectorMay 28Option Exercise3.4730,000104,1001,026,838May 29 04:09 PM
BAKER G LEONARD JRDirectorMay 28Sale15.7030,000471,060996,838May 29 04:09 PM
Swisher Daniel N JRDirectorMay 22Option Exercise6.555,00032,7505,000May 27 07:53 PM
MAHONEY DAVID LDirectorMay 22Option Exercise3.4738,984135,27488,984May 27 07:48 PM
Swisher Daniel N JRDirectorMay 22Sale16.105,00080,5000May 27 07:53 PM
Robb Gary CharlesChief Financial OfficerDec 09Option Exercise1.9230,00057,60038,025Dec 11 04:42 PM
Robb Gary CharlesChief Financial OfficerDec 09Sale13.7330,000412,0298,025Dec 11 04:42 PM
WILSON JAMES NDirectorOct 28Option Exercise2.30284,218653,701400,000Oct 30 05:36 PM
MAHONEY DAVID LDirectorJun 03Option Exercise0.9650,00048,00050,000Jun 04 05:04 PM
BAKER G LEONARD JRDirectorJun 03Option Exercise0.9630,00028,8001,026,838Jun 05 04:24 PM
BAKER G LEONARD JRDirectorJun 03Sale9.7830,000293,298996,838Jun 05 04:24 PM